caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1679650949

Imran AhmedMD

Hematology-OncologyLas Vegas, NVI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Imran Ahmed's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Incorporated
Clinical Laboratory · Las Vegas, NV
2233,772
Nutan Parikh
Hematology-Oncology · Henderson, NV
63719
Inform Diagnostics, Inc.
Clinical Laboratory · Coppell, TX
30513
VALLEY HOSPITAL MEDICAL CENTER2275
C. Milne
Internal Medicine · Las Vegas, NV
1971
SUNRISE MOUNTAINVIEW HOSPITAL, INC.1545
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
1480
Mark Mckenzie
Internal Medicine · Las Vegas, NV
1371
SOUTHERN HILLS MEDICAL CENTER, LLC1381
Medicwest Ambulance, Inc.
Ambulance Service Provider · North Las Vegas, NV
1130
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
9,096
Unique beneficiaries
—
Total services
397,550
Distinct HCPCS
91
Medicare payment
$4.3M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 54 Hematology-Oncology providers in NV — top quintile (cohort median 126,412).
PRESCRIBING · PART D · 2024
Total Rx claims
1,007
Beneficiaries
—
Total drug cost
$3.3M
Distinct drugs
30
Brand share
37.0%
Top prescribed drugs
Anastrozole92 claims
Letrozole76 claims
Apixaban74 claims
Lenalidomide53 claims
Ondansetron49 claims
QUALITY · MIPS · 2024
Final MIPS score
90.1
Quality
73.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.63%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
49
By payment type
Food and Beverage$1K
Education$34